Despite many progresses in both conventional and novel approaches for the treatment of different cancers, but this global health issue still remained challenging. Nutrition plays an important role in human health and also in the course of several diseases (1). Warburg which has a wonderful theory in cancer micro-environment (about acidity and oxygen content of cancer) believed that cancer is not an unresolved problem, rather this is a nutritional problem and usually emerges in people who ate poorly, or not natural diet. In the United States of America, 1,735,350 new cancer cases were diagnosed and 609,640 cancer deaths were happened during 2018 (2). Different nutritional supplements have been used into aiding the therapeutic intervention in cancer patients or for reducing the side effects of conventional therapies (3). On the other hand, anti-oxidant elements are known as the most familiar nutritional factors which have chemo-preventive effects on cancer. This is well accepted that cancer emerges as a result of DNA damage in the presence of free radicals (4). Free radicals could be produced during the normal metabolisms of the cells. The human body always needs scavengers to sweep up free radicals. Anti-oxidants like Vitamin C are the best scavengers for human body (5). But the effect of Vitamin C as a powerful anti-oxidant is not limited to scavenging free radicals. In fact, Vitamin C confers its benefits for cancer patients through multi ways. Warburg suggested that the rate of glucose metabolism in tumor cells is approximately ten-folds more than normal tissues. In aerobic conditions, glucose is converted to lactic acid in cancer cells (6). This high glucose consumption even in the presence of oxygen will result in lactic acid and lower the tumor micro-environment pH (Warburg Effect). In fact, cancer cell metabolism and its range of diversity is considered as its superiority in comparison to normal cell. According to the results of tumor micro-environment researches, in the acidic pH in tumor, the expression of some oncogenes will be facilitated (7).
Results of a recent study showed that the tumor suppression effect of Vitamin C is linked to Ras oncogene metabolomic alterations. In this regard, it is observed that high-dose vitamin C is selectively toxic to human colorectal cancer cells carrying either K-Ras or B-Raf mutations (8). Mutation in K-Ras or B-Raf triggers downstream MAPK pathway, which leads to the up-regulation of GLUT1, a glucose transporter by which Vitamin C can enter to the cancer cells in the form of Dehydro ascorbate.
Dehydro ascorbate in the cells could be reduced back to Vitamin C through oxidization of glutathione. This metabolic pathway results in the depletion of glutathione which is needed for bearing the high levels of intracellular ROS in cancer cells. Therefore, cancer cells will be killed as a result of their own metabolism (9). Regarding to this fact, Vitamin C not only can confer its chemo-preventive role in cancer prophylaxis by free radical scavenger role, but also can impressed the cancer cells with metabolic alteration and make these cells sensitive to their own metabolomics and confer its chemotherapeutic role.
Attention!
NOAH Vitamin C as other Nutritional supplements is NOT
for prevention, treatment or diagnosis of diseases.
References:
1- Nagaraja TG, Galyean ML, Cole NA. Nutrition and disease. Vet Clin North Am Food Anim Pract. 1998 Jul;14(2):257-77.
2- https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2018.html
3- Michael S Donaldson. Nutrition and cancer: A review of the evidence for an anti-cancer diet. Published online 2004 Oct 20. doi: 10.1186/1475-2891-3-19.
4- Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer. 1996 Jan;32A (1):30-8.
5- Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology 2007; 39(1):44-84.
6- Otto Warburg's contributions to current concepts of cancer metabolism. Koppenol WH, Bounds PL, Dang CV Nat Rev Cancer. 2011 May; 11(5):325-37.
7- Wong TS, Liu XB, Chung-Wai Ho A, Po-Wing Yuen A, Wai-Man Ng R, Ignace Wei Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer. 2008 Jul 15; 123(2):251-257.
8- Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, Muley A, Asara JM, Paik J, Elemento O, Chen Z, Pappin DJ, Dow LE, Papadopoulos N, Gross SS, Cantley LC. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 2015 Dec 11; 350(6266):1391-6.
9- Seyeon Park, Seunghyun Ahn, Yujeong Shin, Yoonjung Yang, and Chang H. Yeom. Vitamin C in Cancer: A Metabolomics Perspective. doi: 10.3389/fphys.2018.00762